PT1628988E - Novos compostos em anel de 14 e 15 membros - Google Patents

Novos compostos em anel de 14 e 15 membros Download PDF

Info

Publication number
PT1628988E
PT1628988E PT04732102T PT04732102T PT1628988E PT 1628988 E PT1628988 E PT 1628988E PT 04732102 T PT04732102 T PT 04732102T PT 04732102 T PT04732102 T PT 04732102T PT 1628988 E PT1628988 E PT 1628988E
Authority
PT
Portugal
Prior art keywords
alkyl
hydrogen
optionally substituted
ethyl
oxo
Prior art date
Application number
PT04732102T
Other languages
English (en)
Portuguese (pt)
Inventor
Sulejman Pliva Alihodzic
Andrew Keith Forrest
Richard Lewis Jarvest
Gorjana Pliva Lazarevski
Drazen Pliva Pavlovic
Original Assignee
Glaxo Group Ltd
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Glaxosmithkline Zagreb filed Critical Glaxo Group Ltd
Publication of PT1628988E publication Critical patent/PT1628988E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT04732102T 2003-05-13 2004-05-11 Novos compostos em anel de 14 e 15 membros PT1628988E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
PT1628988E true PT1628988E (pt) 2007-01-31

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04732102T PT1628988E (pt) 2003-05-13 2004-05-11 Novos compostos em anel de 14 e 15 membros

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
EP1851236B1 (en) * 2005-01-13 2010-08-04 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Macrolides with anti-inflammatory activity
WO2006120541A1 (en) * 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
PE20070802A1 (es) * 2005-11-09 2007-10-19 Glaxo Group Ltd Derivados de eritromicina 4''-sustituidos como agentes antimicrobianos
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP2384333B1 (en) 2009-01-30 2013-04-17 Glaxo Group Limited Anti-inflammatory macrolide
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128714T1 (de) * 1989-03-28 1995-10-15 Abbott Lab Erythromycinderivate.
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
US20070185117A1 (en) 2007-08-09
ATE341560T1 (de) 2006-10-15
AR044309A1 (es) 2005-09-07
CA2525452A1 (en) 2004-11-25
HRP20060448T3 (hr) 2007-03-31
GB0310986D0 (en) 2003-06-18
EP1628988A1 (en) 2006-03-01
MXPA05012163A (es) 2006-05-19
CL2004001010A1 (es) 2005-03-18
CN1849328A (zh) 2006-10-18
RU2005134908A (ru) 2006-06-27
DE602004002696T2 (de) 2007-08-16
PL1628988T3 (pl) 2007-03-30
ES2273255T3 (es) 2007-05-01
AU2004238528A1 (en) 2004-11-25
DK1628988T3 (da) 2007-02-05
ZA200509079B (en) 2007-02-28
DE602004002696D1 (de) 2006-11-16
WO2004101586A1 (en) 2004-11-25
EP1628988B1 (en) 2006-10-04
KR20060026407A (ko) 2006-03-23
BRPI0410246A (pt) 2006-05-16
JP2007502313A (ja) 2007-02-08
US7569550B2 (en) 2009-08-04

Similar Documents

Publication Publication Date Title
EP1453846B1 (en) 14 or 15 membered macrolides with antibacterial activity
PT1628989E (pt) Novos compostos anelares com 14 e 15 membros
KR20070085919A (ko) 마크로론 - 아미노 치환된 퀴놀론
ES2331739T3 (es) Macrolidos que contienen enlaces ester utiles para el tratamiento de infecciones microbianas.
PT1628988E (pt) Novos compostos em anel de 14 e 15 membros
CA2525449A1 (en) Macrolides substituded at the 4"-position
JP2008540503A (ja) 細菌感染症の処置に有用なエーテル結合マクロライド
WO2004101589A1 (en) Novel 14 and 15 membered-ring compounds
EP1824871A1 (en) Macrolone compounds
JP2007500193A (ja) 新規な１４−及び１５−員環化合物
CA2566112A1 (en) Carbamate linked macrolides useful for the treatment of microbial infections
EP1879904A1 (en) 4" amino linked macrolides useful for the treatment of microbial infections
WO2004101584A1 (en) Macrolides substituted at the 3-position having antimicrobial activity
KR20070031900A (ko) 미생물 감염의 치료에 유용한 에스테르 연결된마크롤라이드